Your browser doesn't support javascript.
loading
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.
Terrier, Benjamin; Jayne, David R W; Hellmich, Bernhard; Bentley, Jane H; Steinfeld, Jonathan; Yancey, Steven W; Kwon, Namhee; Akuthota, Praveen; Khoury, Paneez; Baylis, Lee; Wechsler, Michael E.
Afiliação
  • Terrier B; Hôpital Cochin, Paris, France.
  • Jayne DRW; University of Cambridge, Cambridge, UK.
  • Hellmich B; Klinik für Innere Medizin, Rheumatologie & Immunologie, Medius Kliniken, Universität Tübingen, Kirchheim-Teck, Germany.
  • Bentley JH; Clinical Statistics, GSK, Brentford, Middlesex, UK.
  • Steinfeld J; Clinical Sciences, Respiratory, GSK, Philadelphia, Pennsylvania.
  • Yancey SW; Respiratory Therapeutic Area, GSK, Research Triangle Park, North Carolina.
  • Kwon N; Clinical Sciences, Respiratory, GSK, Brentford, Middlesex, UK.
  • Akuthota P; University of California, San Diego.
  • Khoury P; Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Baylis L; Global Medical Affairs, GSK, Durham, North Carolina.
  • Wechsler ME; National Jewish Health, Denver, Colorado.
ACR Open Rheumatol ; 5(7): 354-363, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37312233

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ACR Open Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ACR Open Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França